Altered plaque formation by recombinant vaccinia virus expressing simian immunodeficiency virus Nef

被引:3
|
作者
Yamanaka, MK [1 ]
Yilma, T [1 ]
机构
[1] Univ Calif Davis, Int Lab Mol Biol Trop Dis Agents, Dept Vet Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA
关键词
D O I
10.1128/JVI.72.6.5291-5295.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The nef gene of primate lentiviruses encodes a myristoylated protein that is important for pathogenicity and the maintenance of high virus loads. A deletion in nef leads to a significant reduction of the pathogenicity of simian immunodeficiency virus (SIV) in macaques. At the cellular and biochemical levels, Nef has been shown to down-regulate CD4 and major histocompatibility complex class I molecules and to interact with cellular protein kinases. The importance of these activities for Nef function remains uncertain. We have prepared vaccinia virus recombinants expressing different alleles of SIV nef. When grown on TK(-)133 cells, recombinants constructed with the nef allele from SIVmac1A11 produced typical plaques while recombinants expressing the nef allele from SIVmac239-R1 gave rise to plaques with altered morphology. By using chimeric Nef proteins and site-directed mutagenesis, the amino acid responsible for altered plaque formation was mapped to a leucine at residue 211. In vitro phosphorylation of immunoprecipitates prepared from cells infected with the vaccinia virus recombinants resulted in labeled proteins of 62 and 90 kDa. The recombinants differed in the ability to stimulate phosphorylation, and the leucine at residue 211 was again found to be the determining amino acid. These results might help elucidate the role of nef in the pathogenesis of SIV.
引用
收藏
页码:5291 / 5295
页数:5
相关论文
共 50 条
  • [1] Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus
    Chan, KS
    Verardi, PH
    Legrand, FA
    Yilma, TD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) : 8734 - 8739
  • [2] Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1
    Alexander, L
    Du, ZJ
    Howe, AYM
    Czajak, S
    Desrosiers, RC
    JOURNAL OF VIROLOGY, 1999, 73 (07) : 5814 - 5825
  • [3] Evidence for vascular remodeling in the lungs of macaques infected with simian immunodeficiency virus/HIV NEF recombinant virus
    Marecki, J
    Cool, C
    Voelkel, N
    Laciw, P
    Flores, S
    CHEST, 2005, 128 (06) : 621S - 622S
  • [4] Recombinant vaccinia dls expressing simian immunodeficiency virus Gag and Pol in mammalian cells induces efficient cellular immunity as a safe immunodeficiency virus vaccine candidate
    Okamura, Tomotaka
    Someya, Kenji
    Matsuo, Kazuhiro
    Hasegawa, Atsuhiko
    Yamamoto, Naoki
    Honda, Mitsuo
    MICROBIOLOGY AND IMMUNOLOGY, 2006, 50 (12) : 989 - 1000
  • [5] Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene
    Ibuki, K
    Ido, E
    Funahashi, S
    Miura, T
    Hayami, M
    Shida, H
    VACCINE, 1999, 18 (5-6) : 511 - 516
  • [6] Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus
    Osterhaus, ADME
    Tijhaar, E
    Huisman, RC
    Huisman, W
    Darby, IH
    Francis, MJ
    Rimmelzwaan, GF
    Siebelink, KHJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (05) : 437 - 441
  • [7] Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys (Retraction of vol 77, pg 13248, 2003)
    Izumi, Y
    Ami, Y
    Matsuo, K
    Someya, K
    Sata, T
    Yamamoto, N
    Honda, M
    JOURNAL OF VIROLOGY, 2005, 79 (05) : 3229 - 3229
  • [8] Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
    Ourmanov, I
    Brown, CR
    Moss, B
    Carroll, M
    Wyatt, L
    Pletneva, L
    Goldstein, S
    Venzon, D
    Hirsch, VM
    JOURNAL OF VIROLOGY, 2000, 74 (06) : 2740 - 2751
  • [9] MUTATIONAL ANALYSIS OF THE SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC NEF GENE
    BINNINGER, D
    ENNEN, J
    BONN, D
    NORLEY, SG
    KURTH, R
    JOURNAL OF VIROLOGY, 1991, 65 (10) : 5237 - 5243
  • [10] Mice transgenic for simian immunodeficiency virus nef are immunologically compromised
    Larsen, NB
    Kestler, HW
    Docherty, JJ
    JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (04) : 260 - 266